Twin Capital Management Inc Vertex Pharmaceuticals Inc Transaction History

Twin Capital Management Inc

$853 Million
Q3 2024

A detailed history of Twin Capital Management Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Twin Capital Management Inc holds 5,759 shares of VRTX stock, worth $2.35 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

5,759

Previous 5,894 2.29%

Holding current value

$2.35 Million

Previous $2.76 Million 3.04%

% of portfolio

0.31%

Previous 0.33%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$460.0 - $505.78 $62,100 - $68,280	-135 Reduced 2.29%	5,759 $2.68 Million
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $11,784 - $14,565	30 Added 0.51%	5,894 $2.76 Million
Q1 2024 May 13, 2024	SELL	$407.69 - $446.08 $133,722 - $146,314	-328 Reduced 5.3%	5,864 $2.45 Million
Q4 2023 Jan 31, 2024	SELL	$343.0 - $410.68 $55,566 - $66,530	-162 Reduced 2.55%	6,192 $2.52 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $149,137 - $159,844	-441 Reduced 6.49%	6,354 $2.21 Million
Q2 2023 Aug 07, 2023	SELL	$314.42 - $351.91 $82,378 - $92,200	-262 Reduced 3.71%	6,795 $2.39 Million
Q1 2023 May 08, 2023	SELL	$283.23 - $323.1 $1.01 Million - $1.15 Million	-3,564 Reduced 33.56%	7,057 $2.22 Million
Q4 2022 Jan 31, 2023	SELL	$285.76 - $321.48 $9,430 - $10,608	-33 Reduced 0.31%	10,621 $3.07 Million
Q3 2022 Oct 21, 2022	SELL	$273.83 - $305.53 $19,168 - $21,387	-70 Reduced 0.65%	10,654 $3.09 Million
Q2 2022 Aug 02, 2022	BUY	$234.96 - $292.55 $995,055 - $1.24 Million	4,235 Added 65.26%	10,724 $3.02 Million
Q1 2022 May 06, 2022	BUY	$221.42 - $260.97 $18,820 - $22,182	85 Added 1.33%	6,489 $1.69 Million
Q4 2021 Feb 07, 2022	BUY	$177.01 - $223.45 $217,545 - $274,620	1,229 Added 23.75%	6,404 $1.41 Million
Q3 2021 Oct 29, 2021	BUY	$181.39 - $202.99 $938,693 - $1.05 Million	5,175 New	5,175 $939,000
Q1 2019 May 03, 2019	SELL	$163.73 - $194.7 $1.93 Million - $2.29 Million	-11,770 Closed	0 $0
Q4 2018 Feb 04, 2019	SELL	$151.91 - $192.21 $5.08 Million - $6.43 Million	-33,450 Reduced 73.97%	11,770 $1.95 Million
Q3 2018 Nov 08, 2018	BUY	$167.73 - $192.74 $243,208 - $279,473	1,450 Added 3.31%	45,220 $8.72 Million
Q2 2018 Aug 13, 2018	BUY	$145.72 - $169.96 $43,716 - $50,988	300 Added 0.69%	43,770 $7.44 Million
Q1 2018 May 01, 2018	BUY	$151.6 - $177.13 $3.75 Million - $4.38 Million	24,720 Added 131.84%	43,470 $7.09 Million
Q4 2017 Jan 29, 2018	BUY	$137.28 - $155.55 $2.57 Million - $2.92 Million	18,750	18,750 $2.81 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Twin Capital Management Inc with notifications on news.

Account

Twin Capital Management Inc Vertex Pharmaceuticals Inc Transaction History